Home
Conditions
Urologic Neoplasms

Clinical trial condition

Urologic Neoplasms

Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.

2,952 public trials 630 recruiting studies

Refine in advanced search Browse all conditions

Urologic Neoplasms trial results

Active, Not Recruiting

Predictive Impact of MMP2 and MMP9 Levels for Patients With Metastatic Kidney Cancer Treated With Anti-angiogenic Agents

NCT03185039

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney Cancer, +9 more
Locations: Institut Paoli Calmettes Marseille, France

View Trial Details

Active, Not Recruiting

Mannitol Versus Nitroglycerin for Kidney Injury Prevention in Robotic-assisted Radical Prostatectomy or Cystectomy

NCT06408597

Conditions: Acute Kidney Injury, Bladder Cancer, Female Urogenital Diseases, +21 more
Locations: Cairo University Hospitals Cairo, Egypt

View Trial Details

Active, Not Recruiting

Lung US for PEEP Optimization in Robotic Radical Prostatectomy or Cystectomy Patients

NCT06307704

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +18 more
Locations: Cairo University Hospitals Cairo, Egypt

View Trial Details

Active, Not Recruiting

A Window of Opportunity Phase I Study of UGN-201 in Patients With Bladder Cancer Undergoing Radical Cystectomy Protocol #: 2021-0630

NCT05055050

Conditions: Bladder, Bladder Cancer, Female Urogenital Diseases, +10 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

Dose Escalation Study of CLR 131 in Pediatric Relapsed/Refractory Malignant Tumors Including Neuroblastoma and Sarcomas

NCT03478462

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +62 more
Locations: Lucile Packard Children's Hospital Palo Alto, California, United States

Memorial Sloan Kettering Cancer Center New York, United States

Duke University Chapel Hill, North Carolina, United States

Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States

View Trial Details

Active, Not Recruiting

SPECT/CT for the Characterization of Renal Masses

NCT03996850

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney Diseases, +10 more
Locations: UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States

View Trial Details

Active, Not Recruiting

Avelumab in Combination With AVB-S6-500 in Patients With Advanced Urothelial Carcinoma

NCT04004442

Conditions: Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +17 more
Locations: Stephenson Cancer Center Oklahoma City, Oklahoma, United States

View Trial Details

Active, Not Recruiting

A Study to Investigate the Efficacy and Safety of Volrustomig ± Casdatifan vs Nivolumab + Ipilimumab as 1L Treatment for Advanced ccRCC

NCT07000149

Conditions: Adenocarcinoma, Advanced Clear Cell Renal Cell Carcinoma, Carcinoma, +15 more
Locations: Research Site La Jolla, California, United States

Research Site Aurora, Colorado, United States

Research Site Boston, Massachusetts, United States

Research Site New York, United States

View all 32 locations

View Trial Details

Active, Not Recruiting

Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinoma

NCT04940299

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +72 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in Autologous T Cells for Solid Tumors

NCT05103631

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +38 more
Locations: Houston Methodist Hospital Houston, Texas, United States

View Trial Details

Urologic Neoplasms

Urologic Neoplasms trial results

Related conditions